Summary & Overview
HCPCS Q9961: High Osmolar Iodinated Contrast, 250-299 mg/ml
HCPCS Level II code Q9961 represents high osmolar iodinated contrast material at 250–299 mg/ml, billed per milliliter, used to enhance radiographic and fluoroscopic imaging. This code matters nationally because contrast agents are integral to a wide range of diagnostic and interventional imaging procedures; accurate coding of contrast material affects procedure documentation, supply cost accounting, and claims adjudication across payers.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for using high osmolar iodinated contrast, the typical sites of service where it is used, and the implications for billing workflows. The publication provides benchmarks and reference points for reimbursement handling, common billing modifiers applicable to contrast agents, and notes on documentation elements necessary for claims processing.
The content is aimed at revenue cycle staff, clinical coders, and imaging service managers seeking a national perspective on coding and billing considerations for high osmolar iodinated contrast material.
Billing Code Overview
HCPCS Level II code Q9961 describes high osmolar contrast material with an iodine concentration of 250–299 mg/ml, billed per ml. This product is used as an intravascular radiographic contrast agent to enhance imaging studies that require iodine-based contrast enhancement.
-
Service type: Diagnostic or interventional radiology contrast administration
-
Typical site of service: Imaging centers, hospital radiology departments, and outpatient diagnostic facilities
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of peripheral vascular disease and chronic renal insufficiency is scheduled for a contrast-enhanced CT angiography of the abdomen and pelvis to evaluate suspected abdominal aortic aneurysm and assess for branch vessel involvement. The radiology team orders intravascular iodinated contrast; given the clinical scenario a high osmolar contrast agent with iodine concentration in the 250–299 mg/ml range (Q9961) is available and may be used when lower-osmolar agents are contraindicated or unavailable.
The clinical workflow: the ordering clinician documents the indication and relevant comorbidities in the medical record; informed consent for contrast administration is obtained noting risks of nephrotoxicity and allergic reaction; baseline renal function (serum creatinine or eGFR) is reviewed; the radiology nurse prepares the contrast and documents lot number and volume administered; the technologist administers the contrast per protocol during the CT scan; if an adverse reaction occurs, immediate treatment is recorded and appropriate modifiers are appended to billing as indicated; billing uses HCPCS Level II code Q9961 reported per ml of contrast used, with applicable modifiers to reflect service circumstances and any waste/unused product handling (e.g., JW for discarded portion) and technical component/timing modifiers as required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|